7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2)
7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2) Basic information
- Product Name:
- 7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2)
- Synonyms:
-
- 7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2)
- SCH 79797 (hydrochloride)
- infarct,SCH79797 dihydrochloride,SCH-79797 dihydrochloride,SCH-79797,SCH79797,Inhibitor,inhibit,Nonpeptide,thrombin,wortmannin,SCH 79797,antiproliferative,platelets,Protease Activated Receptor (PAR),pro-apoptotic,thrombosis,Thrombin receptors,PAR1,cardioprotection,Apoptosis
- N3-Cyclopropyl-7-(4-isopropylbenzyl)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine dihydrochloride
- SCH79797 dihydrochloride, PAR1 antagonist
- SCH79797 dihydrochloride ,S9916
- CAS:
- 1216720-69-2
- MF:
- C23H26ClN5
- MW:
- 407.95
- Product Categories:
-
- Amines, Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
- Mol File:
- 1216720-69-2.mol
7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2) Chemical Properties
- storage temp.
- Store at 2-8°C, protect from light
- solubility
- Soluble to 25 mM in ethanol and to 50 mM in DMSO
- form
- Powder
- color
- White to yellow
7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2) Usage And Synthesis
Description
SCH 79797 is a non-
Uses
N3-Cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine Dihydrochloride is a selective PAR1 antagonist which was shown to limit myocardial ischemia/reperfusion injury in rat hearts.
Uses
SCH 79797 Dihydrochloride is a selective PAR1 antagonist.
in vivo
SCH79797 (2.5-250 μg/kg; intravenous injection; male Sprague Dawley rats) treatment immediately before or during ischemia reduces myocardial necrosis following I/R in the intact rat heart in two rat models of myocardial ischemia/reperfusion (I/R) injury. This response is dose-dependent with the optimal dose being 25 μg/kg[4].
| Animal Model: | Male Sprague Dawley rats (8 weeks of age) with myocardial I/R injury[4] |
| Dosage: | 2.5 μg/kg, 10 μg/kg, 25 μg/kg, 50 μg/kg, 100 μg/kg, and 250 μg/kg |
| Administration: | Intravenous injection |
| Result: | Immediately before or during ischemia reduced myocardial necrosis following I/R in the intact rat heart. |
IC 50
PAR1
storage
Desiccate at RT
References
[1] HO-SAM AHN. Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists[J]. Bioorganic & Medicinal Chemistry Letters, 1999, 9 14: Pages 2073-2078. DOI: 10.1016/s0960-894x(99)00339-x
[2] HO-SAM AHN . Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist[J]. Biochemical pharmacology, 2000, 60 10: Pages 1425-1434. DOI: 10.1016/s0006-2952(00)00460-3
[3] ELAINE A LIDINGTON. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.[J]. American journal of physiology. Cell physiology, 2005, 289 6: C1437-47. DOI: 10.1152/ajpcell.00502.2004
7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2)Supplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-33632979
- info@tsbiochem.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com